You have 9 free searches left this month | for more free features.

BNT162b2

Showing 1 - 25 of 4,343

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Understand is COVID-19 Vaccine BNT162b2 is Safe in Indonesia

Not yet recruiting
  • COVID-19
  • BNT162b2
  • (no location specified)
Nov 16, 2022

COVID-19 Trial (Bivalent BNT162b2 (original/Omicron BA.4/BA.5) 3 microgram dose, Bivalent BNT162b2 (original/Omicron BA.4/BA.5)

Not yet recruiting
  • COVID-19
  • Bivalent BNT162b2 (original/Omicron BA.4/BA.5) 3 microgram dose
  • +3 more
  • (no location specified)
Dec 22, 2022

SARS-CoV-2 Virus, Severe Acute Respiratory Syndrome Coronavirus 2, COVID-19 Trial (Bivalent BNT162b2 (original/Omicron

Not yet recruiting
  • SARS-CoV-2 Virus
  • +2 more
  • Bivalent BNT162b2 (original/Omicron BA.4/BA.5) 3 microgram dose
  • +4 more
  • (no location specified)
Sep 14, 2022

COVID-19 Trial in Melbourne (Tozinameran, Elasomeran, Bivalent Pfizer-BioNTech)

Not yet recruiting
  • COVID-19
  • Tozinameran
  • +3 more
  • Melbourne, Victoria, Australia
    Royal Children's Hospital, Murdoch Children's Research Institute
Sep 14, 2022

Coronavirus Infections Trial in Beer- Sheva (Pfizer BNT162b2 Vaccine)

Active, not recruiting
  • Coronavirus Infections
  • Pfizer BNT162b2 Vaccine
  • Beer- Sheva, Israel
    Soroka UMC
Aug 24, 2022

Anti COVID-19 Vaccination Campaign Addressed to Employees

Completed
  • COVID-19
  • BNT162b2 COVID-19 Vaccine
  • Roma, RM, Italy
    Fondazione Policlinico Universitario "A. Gemelli" IRCCS
Mar 15, 2023

Intradermal Covid-19 Vaccine, Immungenicity and Safety, Immunocompromised Patients Trial in Hong Kong (ID BNT162b2 vaccine, IM

Recruiting
  • Intradermal Covid-19 Vaccine
  • +3 more
  • ID BNT162b2 vaccine
  • IM BNT162b2 vaccine
  • Hong Kong, Hong Kong
    Queen Mary Hospital
Feb 19, 2023

Response to BNT162b2 Vaccine in Adolescents With Type 1 Diabetes

Completed
  • type1diabetes
  • Blood test
  • Istanbul, Eğitim Mah. Fahrettin Kerim Gökay Caddesi, Kadıköy, Turkey
    Istanbul Medeniyet University, Professor Doctor Suleyman Yalcin
Nov 16, 2022

Covid19 Trial in Miami (BNT162b2 vaccine, JNJ-78436735 Vaccine)

Active, not recruiting
  • Covid19
  • BNT162b2 vaccine
  • JNJ-78436735 Vaccine
  • Miami, Florida
    University of Miami
Aug 1, 2022

Myocardial Injury After BNT162b2 mRNA COVID-19 Fourth Dose

Completed
  • Myocardial Injury
  • +2 more
  • BNT162b2
  • Jerusalem, Israel
    Shaare zedek MC
May 3, 2022

Pfizer-BioNTech COVID-19 BNT162b2 Vaccine Effectiveness Study -

Recruiting
  • COVID-19
  • Primary Exposure Status of Pfizer-BioNTech COVID-19 Vaccine
  • Pasadena, California
    Kaiser Permanente Southern California
Sep 21, 2022

SARS-CoV-2 Trial in Jiangsu (BNT162b2, Placebo)

Completed
  • SARS-CoV-2
  • BNT162b2
  • Placebo
  • Jiangsu, China
    Jiangsu Provincial Center for Disease Control and Prevention
May 9, 2022

Serology After BBIBP-CorV Inactivated Vaccine Combined With

Completed
  • Basic BBIBP-CorV Vaccination is Not as Effective as BNT162b
  • BBIBP-CorV and/or BNT162b2 vaccine
  • Debrecen, Hajdu-Bihar, Hungary
    University of Debrecen
Sep 15, 2022

SARS-CoV-2 Infection, COVID-19 Trial (BNT162b5 Bivalent or BNT162b2 Bivalent 30 µg, BNT162b4 5 µg, BNT162b4 10 µg)

Not yet recruiting
  • SARS-CoV-2 Infection
  • COVID-19
  • BNT162b5 Bivalent or BNT162b2 Bivalent 30 µg
  • +3 more
  • (no location specified)
Sep 14, 2022

COVID-19 Pandemic Trial in Ramat-Gan (BNT162b2 vaccine)

Active, not recruiting
  • COVID-19 Pandemic
  • BNT162b2 vaccine
  • Ramat-Gan, Israel
    Sheba Medical Center
Feb 8, 2022

Immunogenicity of BNT162b2 Covid-19 Vaccine in Elderly People

Completed
  • Immunogenicity, Vaccine
    • Thessaloníki, Thessaloniki, Greece
      G. Gennimatas General Hospital
    Aug 3, 2022

    BNT162b2 mRNA Covid-19 Vaccine Among Children in Brazil

    Not yet recruiting
    • COVID-19
    • Pfizer/BioNTech BNT162b2 mRNA COVID-19 vaccine
    • CoronaVac COVID-19 vaccine
    • Toledo, Paraná, Brazil
      Unidade de Pronto Atendimento (UPA) de Toledo
    May 27, 2022

    Compare mRNA-1273 Versus BNT162b2 COVID-19 Vaccines Among

    Completed
    • SARS-CoV-2
      • New York, New York
        Aetion Inc.
      May 5, 2022

      Chronic Kidney Disease 5D, Chronic Kidney Disease 5T Trial in Istanbul (SARS-CoV-2 mRNA BNT162b2 vaccine (Pfizer-BioNTech®))

      Completed
      • Chronic Kidney Disease 5D
      • Chronic Kidney Disease 5T
      • SARS-CoV-2 mRNA BNT162b2 vaccine (Pfizer-BioNTech®)
      • Istanbul, Turkey
      • +5 more
      Jul 19, 2022

      Healthy, Immunization; Infection Trial in France (3 doses of BNT162b2 vaccine, 2 dose of BNT162b2 vaccine)

      Active, not recruiting
      • Healthy
      • Immunization; Infection
      • 3 doses of BNT162b2 vaccine
      • 2 dose of BNT162b2 vaccine
      • Brest, France
      • +10 more
      Sep 2, 2022

      SARS-CoV2 Infection, Covid19, SARS-CoV-2 Acute Respiratory Disease Trial in Worldwide (BNT162b2, BNT162b2 (B.1.1.7 + B.1.617.2),

      Active, not recruiting
      • SARS-CoV2 Infection
      • +3 more
      • BNT162b2
      • +5 more
      • Long Beach, California
      • +34 more
      Jan 10, 2023

      Haemodialysis Patients to BNT162b2 mRNA Cov-19 Vaccine

      Completed
      • COVID-19 Vaccines
      • Hemodialysis Complication
      • Evaluation of the immunogenicity of the vaccine in haemodialysis patients
      • Lyon, France
      • +1 more
      May 4, 2022

      Infectious Disease, COVID-19 Trial (RVM-V001 10 µg, RVM-V001 30 µg, RVM-V001 60 µg)

      Recruiting
      • Infectious Disease
      • COVID-19
      • RVM-V001 10 µg
      • +2 more
      • Brookvale, New South Wales, Australia
      • +1 more
      Sep 12, 2022

      COVID-19, SARS-CoV-2 Infection Trial in Germany (BNT162b2s01, BNT162b2)

      Active, not recruiting
      • COVID-19
      • SARS-CoV-2 Infection
      • BNT162b2s01
      • BNT162b2
      • Berlin, Germany
      • +3 more
      Jan 12, 2022

      COVID-19 Trial in United States (drug, biological, other)

      Active, not recruiting
      • COVID-19
      • Birmingham, Alabama
      • +21 more
      Feb 2, 2023